New Navigational RFA device for the spinal mets treatment
Posted: Tue Jul 29, 2014 8:36 pm
This new device allows RFA treatment of previously untreatable lesions with resultant reduction in pain that was not controlled by systemic or radiation therapy.
Treatment of Metastatic Spinal Lesions with a Navigational Bipolar Radiofrequency Ablation Device: A Multicenter Retrospective Study
Pain Physician Journal
July/August 2014 - Vol 17 Issue 4
http://www.painphysicianjournal.com/crr ... rent_issue
link to a full PDF is located down that abstract page.
METHOD: One hundred twenty-eight metastatic lesions were identified in 92 patients who underwent a total of 96 procedures. Cement augmentation was performed when the vertebral body was at risk or had a pathological fracture. Visual analogue scale (VAS) scores were obtained preoperatively as well as postoperatively at the one week, one month, and 6 month time points. Interval change in the patients’ pain medications was recorded. Postoperative imaging was used to assess tumor burden at the treated level when available.
RESULTS: RFA was technically successful in all of the lesions without complication or thermal injury.
The study was done at the following institutions (and if you need to find out of this is a good option for you, contact them)
1. Department of
Musculoskeletal Interventional
Radiology Mallinckrodt Institute
of Radiology, St. Louis, MO;
2. Department of Musculoskeletal
Interventional Radiology,
University of California in
San Diego, San Diego, CA;
3. Department of Radiology,
University of Louisville,
Louisville, KY;
4. Department
of Neuro-Oncology, Moffitt
Cancer Center, Tampa, FL;
5. Neuroradiology, Montefiore
Medical Center, New York, NY
The authors
Treatment of Metastatic Spinal Lesions with a Navigational Bipolar Radiofrequency Ablation Device: A Multicenter Retrospective Study
Pain Physician Journal
July/August 2014 - Vol 17 Issue 4
http://www.painphysicianjournal.com/crr ... rent_issue
link to a full PDF is located down that abstract page.
METHOD: One hundred twenty-eight metastatic lesions were identified in 92 patients who underwent a total of 96 procedures. Cement augmentation was performed when the vertebral body was at risk or had a pathological fracture. Visual analogue scale (VAS) scores were obtained preoperatively as well as postoperatively at the one week, one month, and 6 month time points. Interval change in the patients’ pain medications was recorded. Postoperative imaging was used to assess tumor burden at the treated level when available.
RESULTS: RFA was technically successful in all of the lesions without complication or thermal injury.
The study was done at the following institutions (and if you need to find out of this is a good option for you, contact them)
1. Department of
Musculoskeletal Interventional
Radiology Mallinckrodt Institute
of Radiology, St. Louis, MO;
2. Department of Musculoskeletal
Interventional Radiology,
University of California in
San Diego, San Diego, CA;
3. Department of Radiology,
University of Louisville,
Louisville, KY;
4. Department
of Neuro-Oncology, Moffitt
Cancer Center, Tampa, FL;
5. Neuroradiology, Montefiore
Medical Center, New York, NY
The authors